The role of AKR1B10 in modulating the Kras-E-cadherin pathway is further supported by the overexpression, knockdown, and inhibition of the enzyme in pancreatic cancer CD18/HPAF and Panc10.05 cells and xenograft tumors [53,54]. This evidence concerns the gene AKR1B10 and familial pancreatic carcinoma.